13,735 reports of this reaction
3.3% of all PANTOPRAZOLE SODIUM reports
#2 most reported adverse reaction
ACUTE KIDNEY INJURY is the #2 most commonly reported adverse reaction for PANTOPRAZOLE SODIUM, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 13,735 FDA adverse event reports linking PANTOPRAZOLE SODIUM to ACUTE KIDNEY INJURY. This represents approximately 3.3% of all 411,823 adverse event reports for this drug.
PANTOPRAZOLE SODIUM has an overall safety score of 85 out of 100. Patients taking PANTOPRAZOLE SODIUM who experience acute kidney injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACUTE KIDNEY INJURY is moderately reported among PANTOPRAZOLE SODIUM users, representing a notable but not dominant share of adverse events.
In addition to acute kidney injury, the following adverse reactions have been reported for PANTOPRAZOLE SODIUM:
The following drugs have also been linked to acute kidney injury in FDA adverse event reports:
ACUTE KIDNEY INJURY has been reported as an adverse event in 13,735 FDA reports for PANTOPRAZOLE SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACUTE KIDNEY INJURY accounts for approximately 3.3% of all adverse event reports for PANTOPRAZOLE SODIUM, making it one of the most commonly reported side effect.
If you experience acute kidney injury while taking PANTOPRAZOLE SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.